OssDsign reports successful outcome at 6-month follow-up of clinical study on sinus augmentation

OssDsign AB (publ) today announced positive interim results from a clinical study titled: “Safety and performance of granular calcium phosphate in augmentation of the maxillary sinus floor”. This study represents the first use of OssDsign’s proprietary calcium phosphate material in the oral cavity.As previously communicated, OssDsign has been sponsoring a clinical investigation of the safety and performance of the company’s proprietary calcium phosphate material to support bone growth in augmentation of the maxillary sinus floor. This open evaluation study is being performed on 20